Glycobiology 2019 welcomes attendees, presenters and exhibitors from all over the world to Barcelona, Spain. We are delighted to invite you all to attend and register for the “8^th Glycobiology World Congress” which is going to be held during September 23-24, 2019 in Barcelona, Spain.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Glycobiology 2019 where you will be sure to have a meaningful experience with scholars from around the world. All the members of the Glycobiology 2019 organizing committee look forward to meeting you in Barcelona, Spain.

Importance & Scope:

      Most aspects of Glycobiology depend on successful researches. Glycobiology 2019 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Glycobiology leading way to the unraveled. It also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Glycobiology.

Glycobiology 2019 is a quint essential platform for presenting research about marketing, exchanging ideas about it and thus, contributes to the dissemination of knowledge for the benefit of both the academia and business. Glycobiology is where the future intersects. This event brings together eminent researchers and associates to explore the emerging field. We bring together knowledge, creative and technology leaders from the biology industry for the most current and relevant discussions.

Why Barcelona?

Barcelona is the capital city of the autonomous community of Catalonia in the Kingdom of Spain, as well as the country's second most populous municipality, with a population of 1.6 million within city limits. Its urban area extends beyond the administrative city limits with a population of around 4.7 million people, being the sixth-most populous urban area in the European Union after Paris, London, Madrid, the Ruhr area and Milan. It is the largest metropolis on the Mediterranean Sea, located on the coast between the mouths of the rivers Llobregat and Besòs, and bounded to the west by the Serra de Collserola mountain range, the tallest peak of which is 512 metres (1,680 feet) high.

Barcelona has a rich cultural heritage and is today an important cultural centre and a major tourist destination. The city is known for hosting the 1992 Summer Olympics as well as world-class conferences and expositions and also many international sport tournaments. Barcelona is one of the world's leading tourist, economic, trade fair and cultural centres, and its influence in commerce, education, entertainment, media, fashion, science, and the arts all contribute to its status as one of the world's major global cities. It is a major cultural and economic centre in south western Europe, 24th in the world (before Zürich, after Frankfurt) and a financial centre. Barcelona is a transport hub, with the Port of Barcelona being one of Europe's principal seaports and busiest European passenger port, an international airport, Barcelona–El Prat Airport, which handles over 40 million passengers per year, an extensive motorway network, and a high-speed rail line with a link to France and the rest of Europe.

   Glycobiology Market Global Forecast to 2019: The Glycobiology market will reach $928.11 million by 2019, growing at a CAGR of 12.62% during the forecast period (2014–2019). This report segment the global Glycobiology market by application, end users, products, and geographies. According to the World Bank, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S., overall funding for research and development was about $291.77 billion in 2001, which increased to $428.94 billion in 2010. Increased funding activities are expected to positively impact the growth of the Glycobiology enzymes, instruments, kits, and reagents market. A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global Glycobiology enzymes. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. [Source: Ref3]

Conference Highlights:

•        Glycobiology

•        Glycoscience

•        Glycochemistry

•        Cancer Biology

•        Cancer Science

•        Structural Biology

•        NMR and Mass Spectrometry

•        Proteomics

•        Neurobiology

•        Glyco-Bioengineering

•        Stem Cell Therapy

•        Glycosylation

•        Oncology

•        Glyco Immunology

•        Cardiac Cell Biology

•        Biochemistry and Biophysics

•        Glycans in diseases & therapeutics

•        Biomarkers

Why to attend???

MEET YOUR TARGET MARKET with members from around the world focused on learning about Biological research and growing market, this is your single best opportunity to reach the largest assemblage of participants from the scientific community. Conduct demonstrations, distribute information, meet with current and potential customers, and make a splash with a new product line, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Glycobiology growing market are hallmarks of this conference.

Be Part of it!

• This conference focusing on all the major aspects in the fields of Glycobiology and its allied research.

• It would be beneficial for all the students who ever willing to enter into research to the respective fields.

• As bringing the major research to the market and making it to utility are major focus for all the companies, this conference would be opportunity for the people in the respective fields.

Major Glycobiology Associations around the Globe

    Glyconet Glycobiotechnology Network

    Glycoscience Graduate School

    Mizutani Foundation for Glycoscience

    The Japanese Society of Carbohydrate Research

    Alberta Glycomics Centre

    Copenhagen Center for Glycomics

    CKSP: Center of Know-how for Sugars and Polysaccharides, Ben-Gurion University

    Laboratory of Carbohydrate Chemistry, Institute of Bioorganic Chemistry, Russian Academy of Science

    Glycoprotein Structure/Function Group, Birkbeck College

    Oxford Glycobiology Institute

    Centre for Glycobiology, University of Liverpool

    IBS: Institut de Biologie Structurale

 Glycoscience Team, National Centre for Biomedical Engineering Science, National University of Ireland, Galway

Major Glycobiology Related Associations 

Glycosciences Laboratory

Oxford Glycobiology Institute

Glycobiology Group

Glycotechnology Core Resource

Glycobiology Research and Training Center

Glycomics Center

Heparin Home Page, Rensselaer Polytechnic Institute

Resource for Integrated Glycotechnology

Institute of Molecular Biomembrane and Glycobiology

Target Audience:

Directors/Managers & Business Delegates,  Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students and Biomedical Research companies.  

Academia      60%

Industry         30%

Others           10%

Glance at Market of Glycobiology:

The technological progress in biochemistry and molecular biology has played a significant role in the development of the glycobiology market during the last decade. Also, the improvements in analytical instruments, and data processing and analysis software have contributed significantly in the advancement of the glycobiology field. The presence of research funding and government support for conducting research and commercialization of the products in the glycobiology market is the primary driver for the growth of this market. Glycobiology science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the glycobiology market.

The global glycobiology market was valued at $512.38 million in 2014 and poised to grow at a CAGR of 12.62% between 2012 and 2019, to reach $928.11 million in 2019. The rapid increase in research and development expenditure by pharmaceutical and biotech companies, and increased funding in proteomics and glycobiology research will be the two most important growth drivers for this market in the forecast period (2012–2019). Geographic analysis reveals that North America accounted for the largest share of the global glycomics market in 2014, due to increasing funding for proteomics and glycomics research. For instance, in August 2013, the National Institutes of Health (NIH) provided $5.5 million to the National Center for Functional Glycomics (NCFG) for research into the identification of glycans and complex carbohydrates using glycan microarrays. Similarly, in 2011, the University Of Nevada School Of Medicine received $10 million for glycobiology research from NIH. [Source: Ref2]

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S). [Source: Ref1]